A Care Management Intervention for Non-cardiac Chest Pain (NCCP)

May 21, 2021 updated by: Jeff C. Huffman, MD, Massachusetts General Hospital

A Care Management Intervention for Non-cardiac Chest Pain: Intervention Development and Feasibility Assessment

The investigators developed and implemented an eight-week multicomponent care management intervention for non-cardiac chest pain. Team members including a cardiologist, nurse, and psychiatrist. Impressions and recommendations were shared with the patient's primary care physician. Measures of chest pain severity, frequency and impact and measures of psychological health and health-related quality of life were completed at baseline and intervention completion.

Study Overview

Status

Completed

Conditions

Detailed Description

The investigators developed and implemented an eight-week multicomponent care management intervention for non-cardiac chest pain. The care management team consisted of a nurse, cardiologist, and psychiatrist. Following a one-time consultation visit with the cardiologist and nurse, evaluation and treatment recommendations were conveyed to the participant's primary care physician. Then, the nurse completed eight weekly phone calls with the participant to provide support, introduce therapeutic principles, and assist with coordination of care, under the supervision of a psychiatrist. Intervention feasibility was assessed on several domains including adherence, recruitment, attrition, safety, and data collection. To examine preliminary efficacy, participants completed Likert scales of chest pain symptom severity, frequency and impact, and measures of psychological health (Patient Health Questionnaire-9, General Anxiety Disorder-7, Patient Health Questionnaire-15) and health-related quality of life (12-Item Short Form Survey) at baseline and intervention completion.

Study Type

Interventional

Enrollment (Actual)

3

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Massachusetts
      • Boston, Massachusetts, United States, 02114
        • Jeff Huffman

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Diagnosis of non-cardiac chest pain, defined as chest pain recurring at least once per week for two weeks with at least two of the following objective tests: (1) electrocardiogram without ischemic changes; (2) negative cardiac enzymes; (3) non-ischemic cardiac stress test.
  • Primary care physician affiliated with the institution

Exclusion Criteria:

  • History or subsequent diagnosis of cardiac disease
  • Objectively diagnosed alternative medical etiology of chest pain (e.g., gastroesophageal disease)
  • Resolution of chest pain prior to enrollment
  • Cognitive impairment, assessed using a six-item screen
  • Inability to communicate in English
  • Lack of telephone access (precluding weekly phone call participation).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Care Management Intervention for Non-cardiac chest pain
Multicomponent care management intervention.
Multicomponent eight-week care management intervention involving a consultation visit with a cardiologist and nurse. Recommendations from the consultation visit are conveyed to the primary care physician. Following the visit, the participant has eight weekly phone calls with a nurse to provide support, introduce therapeutic principals, and assess symptoms. The study nurse is supervised by a psychiatrist.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Feasibility of adherence
Time Frame: Week 8
A priori, feasible adherence was defined as 100% completion of the consultation visit and a mean completion of at least half of the eight phone calls over the eight-week study period.
Week 8

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Feasibility of recruitment
Time Frame: Baseline
Collect data on the proportion of individuals interested in the study who meet eligibility criteria for participation
Baseline
Feasibility of intervention attrition
Time Frame: Week 8
A priori, an attrition rate of less than or equal to 15% was defined as indicating intervention feasibility
Week 8
Feasibility of intervention safety
Time Frame: Week 8
Any adverse psychological or physical symptoms were documented throughout the study intervention with appropriate follow-up to ensure safety
Week 8
Feasibility of data collection at baseline
Time Frame: Baseline
Assessment of whether participants would be able to complete all baseline study measures
Baseline
Feasibility of data collection at follow-up
Time Frame: Week 8
Assessment of whether participants would be able to complete all follow-up study measures
Week 8
Change in chest pain symptom severity
Time Frame: Change from baseline at week 8
Likert scale from 0 (no pain) to 10 (severe pain)
Change from baseline at week 8
Change in chest pain symptom frequency
Time Frame: Change from baseline at week 8
Likert scale from 0 (infrequent) to 10 (very frequent)
Change from baseline at week 8
Change in chest pain symptom impact
Time Frame: Change from baseline at week 8
Likert scale from 0 (no impact) to 10 (severe impact)
Change from baseline at week 8
Change in depressive symptoms
Time Frame: Change from baseline at week 8
Patient Health Questionnaire-9, score range of 0-27, higher numbers reflect more severe symptoms.
Change from baseline at week 8
Change in anxiety symptoms
Time Frame: Change from baseline at week 8
General Anxiety Disorder-7, score range of 0-21, higher numbers reflect more severe symptoms.
Change from baseline at week 8
Change in somatic symptom disorder/somatization symptoms
Time Frame: Change from baseline at week 8
Patient Health Questionnaire-15, score range of 0-30, higher numbers reflect more severe symptoms.
Change from baseline at week 8
Change in health-related quality of life
Time Frame: Change from baseline at week 8
12-Item Short Form Survey. Generates a physical health composite summary and a mental health composite summary. The mean score is set to 50 for each composite score. Scores > 50 indicate better physical or mental health-related quality of life than the mean, and scores < 50 indicate worse physical or mental health-related quality of life than the mean.
Change from baseline at week 8

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jeff C Huffman, M.D., Massachusetts General Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 22, 2019

Primary Completion (Actual)

January 8, 2020

Study Completion (Actual)

January 8, 2020

Study Registration Dates

First Submitted

May 18, 2021

First Submitted That Met QC Criteria

May 21, 2021

First Posted (Actual)

May 27, 2021

Study Record Updates

Last Update Posted (Actual)

May 27, 2021

Last Update Submitted That Met QC Criteria

May 21, 2021

Last Verified

May 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2017P002331

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chest Pain

Clinical Trials on Care Management Intervention for non-cardiac chest pain

Subscribe